Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Venture Capital & Angel Investors: Washington, D.C.
*Angel Investors: Washington, D.C.
Washington DC Archangels
Finance & Acquisitions: Washington DC ArchAngels (WDCA)
Washington DC ArchAngels (WDCA): Presenting Companies
MICROTRANSPONDER, INC.*

Organization & Developments: MicroTransponder

Parents

*Implantable neurostimulation device to aid stroke recovery and other neurological disorders.
*Incorporates vagus nerve stimulation and wireless technology to deliver targeted electrical impulses
*MicroTransponder is developing a wireless neurostimulation platform for the treatment of chronic pain and other neurological indications
*VIVISTIM PAIRED VNS SYSTEM
2010: National Institute of Mental Health (NIMH) awards a Phase I SBIR grant to MicroTransponder to develop a neurostimulation-based therapy to treat Post Traumatic Stress Disorder-PTSD (2010)
2011: Electric Vagus Nerve Stimulation Shows Promise for Treatment of Noise-Induced Tinnitus (2011)
2019: MicroTransponder awarded $2.6M NINDS SBIR FastTrack U44 grant, announces $7M Series B funding
Dr. Cauller’s device, the NeuT, is 100 times smaller than current devices, operates wirelessly and does not require an internal battery for power.
Dr. Larry Cauller has invented a wireless medical device, capable of being injected with a hypodermic needle that can provide stimulus parameters equivalent to the traditional wired device.